# Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

> **NCT01737424** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 89 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LC28-0126
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01737424
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2014-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737424, "Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01737424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*